Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Enzo Biochem, Inc. (EZB.F)

0.4240
+0.0700
+(19.77%)
At close: April 25 at 8:25:37 AM GMT+2
Loading Chart for EZB.F
  • Previous Close 0.3540
  • Open 0.4240
  • Bid 0.3600 x 120000
  • Ask 0.4400 x 120000
  • Day's Range 0.4240 - 0.4240
  • 52 Week Range 0.0100 - 1.1300
  • Volume 400
  • Avg. Volume 135
  • Market Cap (intraday) 27.154M
  • Beta (5Y Monthly) 1.16
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1200
  • Earnings Date Jun 11, 2025 - Jun 16, 2025
  • Forward Dividend & Yield 0.38 (107.17%)
  • Ex-Dividend Date Nov 15, 2024
  • 1y Target Est --

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.

www.enzo.com

125

Full Time Employees

July 31

Fiscal Year Ends

Recent News: EZB.F

View More

Performance Overview: EZB.F

Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

EZB.F
38.10%
S&P 500 (^GSPC)
6.06%

1-Year Return

EZB.F
51.74%
S&P 500 (^GSPC)
9.44%

3-Year Return

EZB.F
82.13%
S&P 500 (^GSPC)
28.61%

5-Year Return

EZB.F
80.33%
S&P 500 (^GSPC)
94.77%

Compare To: EZB.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EZB.F

View More

Valuation Measures

Annual
As of 4/24/2025
  • Market Cap

    22.67M

  • Enterprise Value

    -10.14M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.71

  • Price/Book (mrq)

    0.45

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -73.25%

  • Return on Assets (ttm)

    -7.46%

  • Return on Equity (ttm)

    -12.94%

  • Revenue (ttm)

    29.09M

  • Net Income Avi to Common (ttm)

    -7.6M

  • Diluted EPS (ttm)

    -0.1200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    40.3M

  • Total Debt/Equity (mrq)

    6.73%

  • Levered Free Cash Flow (ttm)

    -661.12k

Research Analysis: EZB.F

View More

Company Insights: EZB.F

Research Reports: EZB.F

View More